Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
AMGEN
Scientific Title
A Phase 1 Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological Malignancies